electroCore Announces Top Line Results from SAVIOR-1 study of Non-Invasive Vagus Nerve Stimulation (nVNS) in Hospitalized COVID-19 Patients

NEXT STORY
Immutep Achieves Fast Track Designation From US FDA For Efti, A Soluble Lag-3 Protein, In First Line Recurrent/Metastatic Head & Neck Cancer
PREV STORY
Real World Evidence Solution Market Research Report by Component, by Therapeutic Area, by End-User – Global Forecast to 2025 – Cumulative Impact of COVID-19
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Novartis receives positive CHMP opinion for Mayzent® (siponimod) for the treatment of adult patients with active secondary progressive multiple sclerosis (SPMS)

author_avatar
NASDAQ Market News

Diet Doc’s Specialized Diet Plans Instrumental in Helping Pre-Diabetic Patients Prevent Diabetes by Stabilizing Blood Sugar Levels Through Healthy, Safe and Fast Weight Loss

DALLAS, April 18, 2016 (GLOBE NEWSWIRE) -- Scores of Americans are diagnosed with diabetes, ...

author_avatar
NASDAQ Market News

Shire plc : Director/PDMR Shareholding

Director/PDMR Shareholding June 4, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company") ...

author_avatar
NASDAQ Market News